Ahmedabad (Gujarat) [India], August 11: Zydus Lifesciences Limited (including its subsidiaries/ affiliates hereafter referred to as “Zydus”) announced its Q1FY24 results today. Zydus posts Q1FY24 revenues of Rs 5140 crores, a growth of 30% on a YoY basis. Profit After Tax of Rs 1087 crores w
Surat (Gujarat) [India], August 2: BigBloc Construction Ltd, one of India’s largest manufacturers of Aerated Autoclaved Concrete (AAC) Blocks, Bricks and Panels has reported consolidated net profit of Rs 5.90 crore (PAT margin 10.7%) for the Q1 FY 2023-24 ended June 2023, growth of 6.2% Q-o-
Vadodara (Gujarat) [India], June 7: Vadodara-based Maximus International Limited (BSE: MAXIMUS.BO) (BSE: 540401) has achieved remarkable success in the financial year ending on March 31, 2023. With an astounding 44 per cent growth compared to the previous fiscal year, the company's total inc
New Delhi [India], June 2: Kilitch Drugs India Limited is a Leading MSME multinational manufacturer of Injectable in India and Ethiopia, has announced its audited Financial Results for the Q4 & FY23.
New Delhi [India], May 30: Best AgrolifeLimited (BAL) (BSE: 539660, NSE: BESTAGRO) today reported financial results for the Quarter and Year ended March 31st, 2023.
Mumbai (Maharashtra) [India], May 30: Nykaa today announced its financial results for the quarter and full year ended March 31, 2023. Over the last two years, Nykaa has continued to prioritize growth, profitability and creating long-term sustainable value for shareholders, customers and the
The Company has posted annual growth of 27 per cent in revenue, with Total Consolidated Operating Revenue at Rs. 1964 Crores as against Previous Year corresponding figure of Rs.1548 crores. The Company has achieved an EBITDA margin of 20 per cent in Q4 in comparison to Q3 of 17 per cent.
Hyderabad (Telangana) [India], February 1 (ANI/NewsVoir): Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the third quarter of the financial year 2023 ended December 31, 2022.
The pharmaceutical firm's revenue went up 50 per cent y-o-y to Rs 1,545 crore while its Ebitda saw a jump of 39 per cent at Rs 404 crore. Ebitda margins was 26.1 per cent.
Surat (Gujarat) [India], January 24 (ANI/PNN): BigBloc Construction Limited, one of the leading player in the manufacturing of Aerated Autoclaved Concrete (AAC) Blocks, Bricks and Panels has reported a consolidated net profit of Rs 7.70 crore (PAT margin 15.5 per cent) for Q3FY23, growth of
The company said its revenue grew 24 per cent to Rs 20,558 million during the quarter and posted adjusted Ebitda margin at 18.5 per cent. The board has recommended an interim dividend of Rs 19 per share, and the record date for this payout will be February 3, 2023.
The company also announced that its revenue from operations grew 39 per cent to Rs 12,308 million, against Rs 8,853 million in the year-ago period. Earnings before interest, taxes, depreciation, and amortisation grew 112 per cent to Rs 611 million from Rs 288 million during the corresponding